Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Dapansutrile. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dapansutrile SCHEMBL9935165 | 0.97 | — | — | |
| SCHEMBL14325274 | 0.83 | — | — | |
| Dapansutrile SCHEMBL20528619 | 0.81 | — | — | |
| SCHEMBL31390822 | 0.81 | NLRP3 (0.68) | — | |
| SCHEMBL21616866 | 0.79 | NLRP3 (0.65) | — | |
| SCHEMBL18660481 | 0.79 | NLRP3 (0.65) | — | |
| SCHEMBL18660477 | 0.79 | NLRP3 (0.65) | — | |
| SCHEMBL21616867 | 0.79 | NLRP3 (0.65) | — | |
| SCHEMBL9428536 | 0.79 | — | — | |
| Dapansutrile SCHEMBL11291946 | 0.77 | NLRP3 (0.59) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 760 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026099526-A1 | COMBINATION OF INHIBITORS OF IL-1BETA, CCR5 OR CXCR2 CYTOKINE RECEPTORS FOR USE IN THE TREATMENT OF METASTASIS | FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA (ES) | 2026-05-15 | — | — | WO | claimed |
| US-20260091162-A1 | SPRAYABLE POLYMERIC SCAFFOLD LOADED WITH INFLAMMASOME-INHIBITING LIPID NANORODS FOR ANTI-INFLAMMATION THERAPY | KULKARNI ASHISH (US) | 2026-04-02 | — | — | US | claimed |
| US-12582628-B2 | Methods for treating breast cancer | OLATEC THERAPEUTICS, INC. (US) | 2026-03-24 | — | — | US | claimed |
| US-12569463-B2 | Method for treating diabetes | OLATEC THERAPEUTICS, INC. (US) | 2026-03-10 | — | — | US | claimed |
| EP-4701663-A1 | PROLYL HYDROXYLASE DOMAIN-CONTAINING PROTEIN (PHD) INHIBITORS, COMBINATIONS AND USES THEREOF | Insilico Medicine IP Limited (HK) | 2026-03-04 | — | — | EP | claimed |
| US-20250375534-A1 | COMPLEXES FOR DELIVERY OF NUCLEIC ACIDS | BioNTech SE (DE) | 2025-12-11 | — | — | US | claimed |
| US-20250364144-A1 | CANCER PHARMACOPREVENTION THROUGH ARTIFICIAL INTELLIGENCE | UNIV ILLINOIS (US) | 2025-11-27 | — | — | US | claimed |
| EP-3768384-B1 | METHODS FOR TREATING MELANOMA | OLATEC THERAPEUTICS INC (US) | 2025-06-25 | — | — | EP | claimed |
| US-20250177565-A1 | METHODS AND MATERIALS FOR INHIBITING/PREVENTING THE TRAFFICKING OF MONOCYTES TO THE CENTRAL NERVOUS SYSTEM | DARTMOUTH COLLEGE (US) | 2025-06-05 | — | — | US | claimed |
| US-12318361-B2 | Methods for treating cardiovascular diseases | OLATEC THERAPEUTICS, INC. (US) | 2025-06-03 | — | — | US | claimed |
| US-8802885-B2 | Process for preparing 3-methylsulfonylpropionitrile | OLATEC INDUSTRIES LLC (US) | 2014-08-12 | — | — | US | claimed |
| WO-2013184586-A1 | METHOD FOR TREATING SKIN INFLAMMATORY DISEASES | OLATEC INDUSTRIES LLC (US) | 2013-12-12 | — | — | WO | claimed |
| EP-2651407-A2 | 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN | Olatec Industries LLC (US) | 2013-10-23 | — | — | EP | claimed |
| WO-2013130436-A1 | PROCESS FOR PREPARING 3-METHYLSULFONYLPROPIONITRILE | OLATEC INDUSTRIES LLC. (US) | 2013-09-06 | — | — | WO | claimed |
| US-20130225865-A1 | PROCESS FOR PREPARING 3-METHYLSULFONYLPROPIONITRILE | OLATEC INDUSTRIES LLC (US) | 2013-08-29 | — | — | US | claimed |
| CN-103260613-A | 3-methanesulfonylpropionitrile for treating inflammation and pain | OLATEC IND LLC | 2013-08-21 | — | — | CN | claimed |
| US-20130172410-A1 | 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN | OLATEC INDUSTRIES LLC (US) | 2013-07-04 | — | — | US | claimed |
| US-8476316-B2 | 3-methanesulfonylpropionitrile for treating inflammation and pain | OLATEC INDUSTRIES LLC (US) | 2013-07-02 | — | — | US | claimed |
| US-20120157524-A1 | 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN | OLATEC THERAPEUTICS, INC. | 2012-06-21 | — | — | US | claimed |
| WO-2012082718-A2 | 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN | OLATEC INDUSTRIES LLC (US) | 2012-06-21 | — | — | WO | claimed |